Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ATLCAR.CD30.CCR4 cells |
| Trade Name | |
| Synonyms | ATLCAR.CD30-CD28zeta-CCR4 cells |
| Drug Descriptions |
ATLCAR.CD30.CCR4 cells are autologous T-lymphocytes engineered to express CCR4 linked to a chimeric antigen receptor (CAR) targeting CD30 and the CD28 and CD3zeta co-stimulatory domains, which potentially increase antitumor immune response (NCI Drug Dictionary). |
| DrugClasses | CD30 (TNFRSF8) Immune Cell Therapy 5 |
| CAS Registry Number | NA |
| NCIT ID | C155293 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ATLCAR.CD30 cells + ATLCAR.CD30.CCR4 cells | ATLCAR.CD30 cells ATLCAR.CD30.CCR4 cells | 0 | 1 |
| ATLCAR.CD30.CCR4 cells | ATLCAR.CD30.CCR4 cells | 0 | 2 |